Created at Source Raw Value Validated value
Oct. 26, 2020, 8:37 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: 15 eligible patients with moderate to severe COVID-19 in a 1:1 ratio compared to the control group who receive 250 mg metronidazole tablets orally every 6 hours for 7 days in addition to the standard treatment.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO N/AControl group: 15 eligible patients with moderate to severe COVID-19 disease who receive national standard treatment for COVID-19.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 800, "treatment_name": "Metronidazole", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]